# FDA recall D-0505-2026

> **Wells Pharma of Houston LLC** · Class II · drug recall initiated 2026-04-01.

## Product

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

## Reason for recall

cGMP deviations.

## Distribution

U.S. Nationwide.

## Key facts

- **Recall number:** D-0505-2026
- **Recalling firm:** Wells Pharma of Houston LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-04-01
- **Report date:** 2026-05-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Houston, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0505-2026

## Citation

> AI Analytics. FDA recall D-0505-2026. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0505-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*